Disease: Thiopurine S methyltranferase deficiency
- 6-methylmercaptopurine-induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients
- Autoimmune hepatitis with sclerosing cholangitis in a patient with thiopurine methyltransferase deficiency: case presentation
- Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation
- Azathioprine Therapy in a Pediatric TPMT-Deficient Patient-Still an Option
- Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden
- Distribution of Genetic Polymorphisms of Genes Implicated in Thiopurine Drugs Metabolism
- Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry
- Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose
- Metabolite monitoring to guide thiopurine therapy in systemic autoimmune diseases
- Modeling the Outcome of Systematic TPMT Genotyping or Phenotyping Before Azathioprine Prescription: A Cost-Effectiveness Analysis
- Pharmacogenetics: The right drug for you
- Point-Counterpoint: TPMT Genotyping for Azathioprine in Adult Medicine
- Reducing risk in thiopurine therapy
- Severe pancytopenia and aspergillosis caused by thioguanine in a thiopurine S-methyltransferase deficient patient: a case report
- Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods
- Thiopurine S-Methyltransferase Polymorphisms in Korean Dermatologic Patients